Jefferies Group’s Alder Biopharmaceuticals ALDR Stock Holding History

Jefferies Group’s Portfolio ALDR Stock Details ALDR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-40,000	Closed	-$754K	–	3266
2019 Q3	$754K	Buy	+40,000	New	+$457K	0.01%	1669

Jefferies Group's ALDR Position: Q4 2019 in Review

Jefferies Group sold out of Alder Biopharmaceuticals (ALDR) in Q4 2019, closing a stake of 100,790 shares — an estimated $1.9M sold.

Jefferies Group first reported a position in ALDR in Q3 2019 and held it in 1 quarter. The position peaked at $1.9M in Q3 2019. 0 funds tracked by Wall St. Rank hold ALDR as of Q4 2019.

Jefferies Group reported no remaining Alder Biopharmaceuticals position as of Q4 2019 after selling out during the quarter.
Jefferies Group sold 100,790 Alder Biopharmaceuticals shares in Q4 2019, an estimated $1.9M.
Jefferies Group first reported a position in Alder Biopharmaceuticals in Q3 2019 and held it in 1 quarter.
Jefferies Group's Alder Biopharmaceuticals position peaked at $1.9M in Q3 2019.
0 funds tracked by Wall St. Rank held Alder Biopharmaceuticals as of Q4 2019.

Based on Jefferies Group's 13F filing for Q4 2019, filed 13 Feb 2020.